44.97
1.60
(3.69%)
1.0M
XNAS Volume
XNAS 24 Jun, 2025 11:09 AM (EDT)
Postive Trial
Exelixis rises on Monday as its cancer drug combo shows positive results in phase-3 trial
See details
